First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
Saved in:
| Title: | First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients. |
|---|---|
| Authors: | Moiseyenko, Vladimir M.1, Moiseyenko, Fedor V.1,2,3, Yanus, Grigoriy A.2,4, Kuligina, Ekatherina Sh.2, Sokolenko, Anna P.2,4, Bizin, Ilya V.5, Kudriavtsev, Alexey A.1, Aleksakhina, Svetlana N.2, Volkov, Nikita M.1, Chubenko, Vyacheslav A.1, Kozyreva, Kseniya S.1, Kramchaninov, Mikhail M.1,4, Zhuravlev, Alexandr S.1, Shelekhova, Kseniya V.1, Pashkov, Denis V.6, Ivantsov, Alexandr O.2,4, Venina, Aigul R.2, Sokolova, Tatyana N.2, Preobrazhenskaya, Elena V.2,4, Mitiushkina, Natalia V.2 |
| Source: | Clinical Drug Investigation. Jun2018, Vol. 38 Issue 6, p553-562. |
| Database: | SPORTDiscus with Full Text |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
